Active Pharmaceutical Ingredients (API) Market Value


Pune, June 06, 2022 (GLOBE NEWSWIRE) — The Global Active Pharmaceutical Ingredients (API) Market is expected to reach approximately US$353.08 billion by 2031 According to a report published by Growth Plus Reports “Active Pharmaceutical Ingredient (API) Market by Type [Generic and Branded]Manufacturer Type [Merchant (Contract) Manufacturers and Captive (In-House) Manufacturers]Application [Cardiovascular Disease, Infectious Diseases, Oncology, Neurological Diseases, Diabetes, and Respiratory Diseases] – The Global Outlook and Forecast 2021-2031 market size was worth $186 billion in 2020 and is expected to grow at a CARG of 6% over the forecast period 2021-2031 due to increased R&D activities and the launch of various new and generic drugs to address unmet clinical needs.

Request a sample of this research report @

Growth factors

The rapid spread of the coronavirus disease (Covid-19) in almost all countries of the world has led to serious consequences in all regions.

The first case of Covid-19 was discovered in December 2019, and by the end of December 2020 the number jumped to over 90.3 million worldwide.

Due to the global increase in Covid-19 cases, the need for effective treatments has multiplied. Government agencies and several leading players are constantly striving to speed up the process of drug development for Covid-19.

For example, in May 2020, the US Department of Health and Human Services (HHS) announced that it would provide $354 million under a four-year contract to Phlow Corporation to produce active pharmaceutical ingredients ( APIs) needed for drugs to treat patients with Covid. -19 years and related illnesses.

The global Active Pharmaceutical Ingredients (APIs) market has been analyzed from four different angles: type, type of manufacturer, application, and region.


However, the capital investment and high production cost of API is expected to restrain the market to some extent. The construction of production facilities according to cGMP standards, its maintenance and the installation of technologies and large equipment require heavy investments which are likely to hamper the growth of the market.

Report scope and segmentation

Report cover Details
Forecast period 2021 to 2031
Forecast Period 2021 to 2031 CAGR 6%
Market size in 2031 $353.08 billion
Base year for the estimate 2020
Number of pages 100 – 120
Segments Covered Type, manufacturer type, application

Excerpts from ‘By Application Segmentation’

The global Active Pharmaceutical Ingredients (APIs) market has been majorly segmented into seven distinct categories on the basis of application, namely:

  • Heart disease
  • Infectious diseases
  • Oncology
  • Neurological diseases
  • Diabetes
  • Respiratory diseases
  • Others (pain management, orthopaedics, urinary tract disorders, ophthalmology, gastroenterology, etc.).

Oncology segment is expected to be the fastest growing application segment during the forecast period.

The growth of the segment can be attributed to the rising prevalence of different types of cancers across the world, growing demand for effective cancer treatments, and large number of ongoing clinical trials for the treatment of cancer.

Ask here for more customization study @

Excerpts from ‘Segmentation by region’

Global Active Pharmaceutical Ingredients (API) Market has been segmented into:-

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World (RoW).

North America is expected to hold the largest share of the global Active Pharmaceutical Ingredients (APIs) market, followed by Asia-Pacific, Europe and Rest of the World (RoW).

Factors such as the growing prevalence of acute and chronic diseases, increasing government initiatives for the production of generic drugs, the high number of ongoing R&D activities and the presence of major pharmaceutical and biotechnology companies in the region are expected to fueling market growth.

Excerpts from “Competitive Landscape”

Leading players operating in the Global Active Pharmaceutical Ingredients (APIs) Market are:-

  • Sun Pharmaceutical Industries Ltd
  • Merck KGaA
  • GlaxoSmithKline plc
  • Cipla Inc.
  • Pfizer Inc.
  • Sanofi SAIS
  • Lily
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Teva Pharmaceutical Industries Ltd
  • Among others

Market segmentation

Growth Plus Reports has segmented the global Active Pharmaceutical Ingredients (APIs) market on Type, Manufacturer Type, Application
Seize the perspectives:

Manufacturer Type Outlook:

  • Merchant manufacturers (under contract)
  • Captive manufacturers (internal)

Application Prospects:

  • Heart disease
  • Infectious diseases
  • Oncology
  • Neurological diseases
  • Diabetes
  • Respiratory diseases


  • Fueled by free analyst hours and expert interviews with every report
  • Comprehensive quantitative and qualitative information at segment and sub-segment level
  • Trends and perspectives of the impact of Covid 19
  • Granular information at global/regional/country level
  • In-depth insights into market dynamics (drivers, restraints, opportunities) and business environment
  • Global coverage of the competitive landscape
  • Winning imperatives
  • Comprehensive coverage of “strategic developments” recorded by major market players


  • Distributor Landscape Assessment
  • Pricing information
  • Customer evaluation
  • Analysis of investments and initiatives
  • ‘Company Profile’ of key players

Buy this Premium Research Report @

About Us:

Growth+Reports is part of GRG Health, a global healthcare knowledge services company. We are proud members of the EPhMRA (European Pharmaceutical Marketing Research Association).

The Growth+ portfolio of services leverages our core capabilities in secondary and primary research, market modeling and forecasting, benchmarking, analysis and strategy formulation to help clients create scalable and game-changing solutions. that prepare them for future growth and success.

We have been recognized by the prestigious CEO Magazine as “The Most Innovative Market Research Company in the Healthcare Market of 2020.


Comments are closed.